Haumann Rianne, 't Hart Elvin, Derieppe Marc P P, Besse Helena C, Kaspers Gertjan J L, Hoving Eelco, van Vuurden Dannis G, Hulleman Esther, Ries Mario
Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, Cancer Center Amsterdam; Princess Máxima Center for Pediatric Oncology;
Princess Máxima Center for Pediatric Oncology.
J Vis Exp. 2020 Jul 16(161). doi: 10.3791/61269.
The blood-brain barrier (BBB) has been a major hurdle for the treatment of various brain diseases. Endothelial cells, connected by tight junctions, form a physiological barrier preventing large molecules (>500 Da) from entering the brain tissue. Microbubble-mediated focused ultrasound (FUS) can be used to induce a transient local BBB opening, allowing larger drugs to enter the brain parenchyma. In addition to large-scale clinical devices for clinical translation, preclinical research for therapy response assessment of drug candidates requires dedicated small animal ultrasound setups for targeted BBB opening. Preferably, these systems allow high-throughput workflows with both high-spatial precision as well as integrated cavitation monitoring, while still being cost effective in both initial investment and running costs. Here, we present a bioluminescence and X-ray guided stereotactic small animal FUS system that is based on commercially available components and fulfills the aforementioned requirements. A particular emphasis has been placed on a high degree of automation facilitating the challenges typically encountered in high-volume preclinical drug evaluation studies. Examples of these challenges are the need for standardization in order to ensure data reproducibility, reduce intra-group variability, reduce sample size and thus comply with ethical requirements and decrease unnecessary workload. The proposed BBB system has been validated in the scope of BBB opening facilitated drug delivery trials on patient-derived xenograft models of glioblastoma multiforme and diffuse midline glioma.
血脑屏障(BBB)一直是各种脑部疾病治疗的主要障碍。由紧密连接相连的内皮细胞形成了一道生理屏障,可阻止大分子(>500道尔顿)进入脑组织。微泡介导的聚焦超声(FUS)可用于诱导血脑屏障短暂局部开放,使更大的药物能够进入脑实质。除了用于临床转化的大型临床设备外,对候选药物治疗反应评估的临床前研究还需要专门的小动物超声设备来实现靶向性血脑屏障开放。理想情况下,这些系统应允许高通量工作流程,具备高空间精度以及集成的空化监测功能,同时在初始投资和运行成本方面仍具有成本效益。在此,我们展示了一种基于市售组件且满足上述要求的生物发光和X射线引导的立体定向小动物FUS系统。特别强调了高度自动化,以应对高容量临床前药物评估研究中通常遇到的挑战。这些挑战包括需要标准化以确保数据可重复性、减少组内变异性、减少样本量从而符合伦理要求以及减少不必要的工作量。所提出的血脑屏障系统已在多形性胶质母细胞瘤和弥漫性中线胶质瘤患者来源异种移植模型的血脑屏障开放促进药物递送试验范围内得到验证。